Digital-Pathology-Today Podcast Por Magpie Communications arte de portada

Digital-Pathology-Today

Digital-Pathology-Today

De: Magpie Communications
Escúchala gratis

Acerca de esta escucha

 Digital Pathology Today, the only podcast for professionals interested in the field of digital pathology and artificial intelligence in a clinical setting. This interview-style podcast features industry leaders, key academics, and top pathologists discussing the past, present and future of digital pathology. Hosted by pathologist, Dr. Joseph Anderson, each weekly episode discusses topics from artificial intelligence to regulation and much more. “We hope to bring news and information to anyone interested in the field of digital pathology,” said Digital Pathology Today host, Dr. Joseph Anderson. “With so many advances and innovations taking place, we know that Digital Pathology Today will be a valuable source of information for our listeners.”Copyright Magpie Communications Ciencia Ciencias Biológicas Enfermedades Físicas Hygiene & Healthy Living Política y Gobierno
Episodios
  • May 2025 Digital Pathology Roundup

    May 2025 Digital Pathology Roundup
    Jun 30 2025
    Here is May's Digital Patholog Roundup with Imogen Fitt of Signify Research. 1. Digital Pathology as a Service (DPaaS): Histofy and Source BioScience announced a strategic partnership to enhance diagnostic workflows, starting with efficiency improvements and later expanding to deploy Histofy’s AI tools across Source’s UK-wide operations. Notably, Source BioScience is the UK’s largest histopathology provider and had previously acquired LD Path in 2022. This move reinforces the emerging trend of service-based digital pathology models, as seen with Inify Laboratories and PathologyWatch. 2. Platform Integrations: French AI company Bioptimus launched its H-optimus-1 model on AWS Marketplace, improving accessibility for life sciences. Meanwhile, Labcorp introduced an integrated digital pathology platform across its central labs, combining Leica Biosystems’ Aperio GT450 scanners with Proscia’s Concentriq LS system. The initiative aims to streamline scanning, archival, and companion diagnostic development for global clinical trials. 3. Artificial Intelligence: At Microsoft’s #Build2025, the company launched its Healthcare Multi-Agent Orchestrator, which includes Paige's Alba co-pilot for image-based pathology queries. Additionally, PictorLabs partnered with PathPresenter to integrate AI-based virtual staining into PathPresenter’s platform. Users can now apply virtual H&E, IHC, and special stains instantly on whole slide images for education, research, and clinical use—though FDA approval is still pending for PictorLabs’ solution. 4. Funding: Medmain Inc. raised $3.3 million to enhance its PidPort image management system, expand infrastructure, and pursue regulatory approval for its AI tools. This brings 2025’s total Digital Pathology VC funding to $168 million across 10 vendors, reflecting strong investor interest.
    Más Menos
    13 m
  • April 2025 Digital Pathology Roundup

    April 2025 Digital Pathology Roundup
    Jun 1 2025
    April’s Digital pathology Roundup with Imogen Fitt of Signify Research reflects strong momentum in digital pathology integrations, global AI expansion, and regulatory milestones. Partnerships & Integrations: Visiopharm + Indica Labs: Visiopharm’s Discovery image analysis software is now integrated into Indica Labs’ HALO Link (v4.1) platform. This paid add-on allows seamless viewing of annotations, ROIs, and analysis summaries across platforms. Paige + Burjeel Holdings: Paige’s AI solutions will be deployed across Burjeel’s 100 healthcare facilities in the MENA region (UAE, Saudi Arabia, Oman), expanding access to AI-powered pathology. Paige + Sectra: Sectra will distribute Paige’s AI tools, enhancing Sectra’s digital offerings in radiology, cardiology, and pathology. Mindpeak + DigitCells: Mindpeak’s AI algorithms will be integrated into DigitCells’ platform to enhance pathology automation. Google Cloud + Endeavor Health: New cloud-based platform aims to accelerate diagnosis, facilitate second opinions, and enable direct patient-pathologist engagement by allowing patients to view images and consult with pathologists. Regulatory Approvals: VIEWORKS: Korea’s VIEWORKS received CE IVDR certification for its VISQUE DPS LH510 scanner (supports tissue & cytology). The company plans European expansion. Roche: FDA granted Breakthrough Device Designation to Roche’s VENTANA® TROP2 CDx—first digital pathology companion diagnostic to receive this designation. Funding: Gestalt Diagnostics: Raised $7.5M Series A (total $12M) led by Cowles Ventures and others. Funds will accelerate AI development, commercialization, and FDA approval efforts. Leidos + Univ. of Pittsburgh: Leidos committed $10M over 5 years to fund the Computational Pathology Center, advancing research and clinical AI applications. Clinical Pilots: Region Skåne (Sweden): Initiated proof-of-concept for Paige’s Prostate Suite. Success may drive broader regional adoption. Listen to Digital Pathology Today on all major podcast platforms.
    Más Menos
    13 m
  • March 2025 Digital Pathology Roundup

    March 2025 Digital Pathology Roundup
    May 1 2025
    March saw major developments across digital pathology, including regulatory milestones, foundational AI models, strategic partnerships, and significant funding wins. Regulatory Approvals: Epredia earned FDA 510(k) clearance for its high-volume E1000 Dx Digital Pathology Solution, capable of digitizing up to 1,500 slides per day. Despite the hardware’s impressive capacity and features like dual slide processing and automated quality control, its immediate clinical appeal may be tempered by institutions’ preference for redundancy over sheer throughput. Still, Epredia’s longstanding customer trust and emphasis on quality may help drive early adoption. Meanwhile, PathAI received EMA qualification for its AIM-MASH AI tool, which standardizes biopsy scoring for MASH trials—well timed given the FDA’s recent approval of the first drug for the condition. Foundation Models & Large Datasets: Bioptimus launched ‘H-optimus-1,’ a massive pathology foundation model trained on over 1 million H&E slides from 800,000+ patients. It more than doubles the dataset used for their previous model and builds momentum following January’s major funding round. At HIMSS, HistAI debuted its SPIDER initiative, aiming to create a 50-million-image open-source dataset covering 20 organs. The first release includes 3 pretrained models targeting skin, colorectal, and lung—an ambitious step toward accelerating AI discovery and collaboration. Partnerships: Quest Diagnostics teamed up with Google Cloud to deploy generative AI for enhanced data analytics and customer experience. While not immediately diagnostic, such tools are paving the way for future clinical AI applications. Funding: Proscia raised $50 million in a round led by Insight Partners, boosting its total funding to $130 million. The funds will support platform adoption, AI enhancements, and deeper collaborations with Agilent and Siemens. The company also hinted at a future IPO—marking a promising trajectory for this digital pathology innovator.
    Más Menos
    10 m
Todavía no hay opiniones